Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Curr Treat Options Infect Dis. 2018 Mar 5;10(1):107–120. doi: 10.1007/s40506-018-0144-1

Table 1.

Summary of key studies of post-transplant patient and graft survival for HIV+ individuals.

Study N Organ Patient Survival Graft Survival

1-year 3-year 5-year 10-year 1-year 3-year 5-year 10-year
Stock, et al. 2010 [37] 150 Kidney 95% 91% ND ND 90% 77% ND ND
Locke, et al. 2015 [41] 362 Kidney 96% 92% 88% 64% 90% 82% 75% 56%
Terrault, et al. 2012 [38] 89 Liver 76% 60% ND ND 72% 53% ND ND
Locke, et al. 2016 [46]* 180 Liver 77% 62% 58% 41% 73% 58% 51% 35%
*

Many of the individuals included in the registry data [41,46] are also participants in the clinical trials [41,46]

ND - no data